Lele Cong

540 total citations
23 papers, 374 citations indexed

About

Lele Cong is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lele Cong has authored 23 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Lele Cong's work include Cancer-related molecular mechanisms research (5 papers), melanin and skin pigmentation (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Lele Cong is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), melanin and skin pigmentation (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Lele Cong collaborates with scholars based in China and Netherlands. Lele Cong's co-authors include Xianling Cong, Zilong Zhou, Hongyan Sun, Hongyan Sun, Miao Hao, Dan Dang, Zheng Yang, Chuan Zhang, Nan Wu and Tie Liu and has published in prestigious journals such as Molecular Therapy, Knowledge-Based Systems and Frontiers in Oncology.

In The Last Decade

Lele Cong

23 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lele Cong China 10 157 115 92 62 42 23 374
Saima Usman United Kingdom 6 170 1.1× 108 0.9× 82 0.9× 20 0.3× 38 0.9× 9 343
Kevinn Eddy United States 10 200 1.3× 126 1.1× 71 0.8× 34 0.5× 139 3.3× 14 399
Ashkan Shahbandi United States 7 231 1.5× 200 1.7× 124 1.3× 47 0.8× 112 2.7× 11 507
Zhongling Luo China 14 199 1.3× 101 0.9× 44 0.5× 19 0.3× 95 2.3× 25 429
Nóra Meggyesházi Hungary 13 238 1.5× 103 0.9× 69 0.8× 214 3.5× 39 0.9× 27 556
Zoufang Huang China 12 218 1.4× 118 1.0× 67 0.7× 43 0.7× 84 2.0× 28 418
Sijia Wang China 10 228 1.5× 92 0.8× 120 1.3× 23 0.4× 72 1.7× 21 397
Abel Soto-Gamez Netherlands 9 209 1.3× 50 0.4× 54 0.6× 31 0.5× 101 2.4× 15 438
Dionne Davis United States 8 147 0.9× 172 1.5× 52 0.6× 25 0.4× 110 2.6× 10 472

Countries citing papers authored by Lele Cong

Since Specialization
Citations

This map shows the geographic impact of Lele Cong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lele Cong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lele Cong more than expected).

Fields of papers citing papers by Lele Cong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lele Cong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lele Cong. The network helps show where Lele Cong may publish in the future.

Co-authorship network of co-authors of Lele Cong

This figure shows the co-authorship network connecting the top 25 collaborators of Lele Cong. A scholar is included among the top collaborators of Lele Cong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lele Cong. Lele Cong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cong, Lele, et al.. (2024). A novel long non-coding RNA SLNCR1 promotes proliferation, migration, and invasion of melanoma via transcriptionally regulating SOX5. Cell Death Discovery. 10(1). 160–160. 4 indexed citations
2.
Yu, Bo, Peng Yin, Hechang Chen, et al.. (2023). Pyramid multi-loss vision transformer for thyroid cancer classification using cytological smear. Knowledge-Based Systems. 275. 110721–110721. 4 indexed citations
3.
Cong, Lele, et al.. (2023). Effect of anti-skin disorders of ginsenosides- A Systematic Review. Journal of Ginseng Research. 47(5). 605–614. 24 indexed citations
4.
Yu, Bo, Hechang Chen, Yunke Zhang, et al.. (2022). Data and knowledge co-driving for cancer subtype classification on multi-scale histopathological slides. Knowledge-Based Systems. 260. 110168–110168. 4 indexed citations
5.
Cong, Lele, Hongfeng Yang, Hongyan Sun, et al.. (2021). Role of Circular RNAs in the Pathogenesis of Malignant Melanoma. Critical Reviews in Eukaryotic Gene Expression. 32(3). 21–30. 1 indexed citations
6.
Han, Yali, Xiaqing Yu, Yuzhen Yin, et al.. (2021). Identification of Potential BRAF Inhibitor Joint Therapy Targets in PTC based on WGCAN and DCGA. Journal of Cancer. 12(6). 1779–1791. 9 indexed citations
7.
Zhou, Zilong, Lele Cong, & Xianling Cong. (2021). Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank. Frontiers in Oncology. 11. 762184–762184. 111 indexed citations
8.
Cong, Lele, et al.. (2021). Effect of EG00229 on Radiation Resistance of Lung Adenocarcinoma Cells. Journal of Cancer. 12(20). 6105–6117. 10 indexed citations
9.
Yang, Zheng, Hongyan Sun, Lele Cong, et al.. (2021). Prognostic Value of ctDNA Mutation in Melanoma: A Meta-Analysis. Journal of Oncology. 2021. 1–13. 9 indexed citations
10.
Wu, Nan, Hongyan Sun, Lele Cong, et al.. (2020). A meta-analysis of fractional CO2 laser combined with PRP in the treatment of acne scar. Lasers in Medical Science. 36(1). 1–12. 19 indexed citations
11.
Sun, Qian, Hongyan Sun, Lele Cong, et al.. (2020). <p>Effects of Exogenous Hormones and Reproductive Factors on Female Melanoma: A Meta-Analysis</p>. Clinical Epidemiology. Volume 12. 1183–1203. 9 indexed citations
12.
Liu, Xilin, Hong Li, Xianling Cong, et al.. (2020). <p>α-MSH-PE38KDEL Kills Melanoma Cells via Modulating Erk1/2/MITF/TYR Signaling in an MC1R-Dependent Manner</p>. OncoTargets and Therapy. Volume 13. 12457–12469. 6 indexed citations
13.
Sun, Hongyan, et al.. (2020). Prognostic Significance of Tumor-Infiltrating Lymphocyte Grade in Melanoma: A Meta-Analysis. Dermatology. 236(6). 481–492. 11 indexed citations
14.
Ma, Yu‐Shui, Fei Yu, Xiaoming Zhong, et al.. (2018). miR-30 Family Reduction Maintains Self-Renewal and Promotes Tumorigenesis in NSCLC-Initiating Cells by Targeting Oncogene TM4SF1. Molecular Therapy. 26(12). 2751–2765. 35 indexed citations
16.
Cong, Lele, Xiangyi Kong, Jing Wang, et al.. (2018). Association between SORL1 polymorphisms and the risk of Alzheimer's disease. Journal of Integrative Neuroscience. 17(2). 185–192. 9 indexed citations
17.
Luo, Pei, Qing Yang, Lele Cong, et al.. (2017). Identification of miR-124a as a novel diagnostic and prognostic biomarker in non-small cell lung cancer for chemotherapy. Molecular Medicine Reports. 16(1). 238–246. 16 indexed citations
18.
Bai, Lifei, et al.. (2017). A novel ratiometric fluorescent probe for cyanide anion with high selectivity and its application in cell imaging. Chemical Research in Chinese Universities. 33(4). 534–539. 7 indexed citations
19.
Cong, Lele, Xiangyi Kong, Jing Wang, et al.. (2017). Association between SORL1 polymorphisms and the risk of Alzheimer’s disease. Journal of Integrative Neuroscience. 17(2). 239–251. 8 indexed citations
20.
Zhang, Yaqin, Yuqian Wang, Lele Cong, Hongfeng Yang, & Xianling Cong. (2015). Eyelid sporotrichosis: Unique clinical findings in 72 patients. Australasian Journal of Dermatology. 57(1). 44–47. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026